Neoadjuvant Chemo-Endocrine Therapy for Hormone Receptor Positive Breast Cancer: A Meta-Analysis
Background: Neoadjuvant chemotherapy has become the standard treatment for patients with locally advanced breast cancer. However, patients with hormone receptor positive (especially human epidermal growth receptor 2 negative) breast cancer show low response rate to neoadjuvant chemotherapy. Whether...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
IMR Press
2023-04-01
|
| Serie: | Clinical and Experimental Obstetrics & Gynecology |
| Soggetti: | |
| Accesso online: | https://www.imrpress.com/journal/CEOG/50/4/10.31083/j.ceog5004074 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|